Currently the most common and widespread cervical HPV vaccine in China is the quadrivalent cervical cancer HPV vaccine. But relatively the best cervical cancer vaccine in the world is the cervical cancer nine-valent vaccine, because the coverage of HPV virus prevention will be more extensive. The quadrivalent cervical cancer vaccine is now all self-pay in China, and usually requires three shots, one of which is about 800 yuan, so it adds up to more than 2,000 yuan in total. The cervical cancer vaccine is all self-financed, so basically the pricing is related to the price bureau, and the difference between each place is not particularly obvious. The domestic stock is now quadrivalent, but the nine-valent cervical cancer vaccine will be available soon after this year. The nine-valent cervical cancer vaccine is currently available online for reservation, and the price is not particularly clear yet. For reference, the nine-valent cervical cancer vaccine in Hong Kong is generally 3,000-4,000 yuan, which is also a total of three shots. The pricing of the nine-valent vaccine will only be known after the domestic market launch, so the current price of the domestic cervical cancer quadrivalent vaccine is more than 2,000 yuan.